The Enterprise Value as of December 2025 (TTM) for Arch Biopartners Inc. (ACHFF) is 86.23M

According to Arch Biopartners Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 86.23M. This represents a change of -28.76% compared to the average of 121.04M of the last 4 quarters.

Arch Biopartners Inc. (ACHFF) Historical Enterprise Value (quarterly & annually)

How has ACHFF Enterprise Value performed in the past?

The mean historical Enterprise Value of Arch Biopartners Inc. over the last ten years is 78.78M. The current 86.23M Enterprise Value has changed 10.85% with respect to the historical average. Over the past ten years (40 quarters), ACHFF's Enterprise Value was at its highest in in the March 2022 quarter at 266.79M. The Enterprise Value was at its lowest in in the September 2015 quarter at 15.93M.

Arch Biopartners Inc. (ACHFF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arch Biopartners Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arch Biopartners Inc. (ACHFF) Average Enterprise Value

How has ACHFF Enterprise Value performed in the past?

The current Enterprise Value of Arch Biopartners Inc. (ACHFF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Arch Biopartners Inc. (ACHFF) Enterprise Value vs. Peers

How is ACHFF’s Enterprise Value compared to its peers?

Arch Biopartners Inc.’s Enterprise Value is greater than Relief Therapeutics Holding AG (24.05M), greater than Amplia Therapeutics Limited (53.28M), greater than PsyBio Therapeutics Corp. (135.91K), greater than Oncotelic Therapeutics, Inc. (58.52M), greater than Relief Therapeutics Holding AG (24.05M), less than Helix BioPharma Corp. (178.01M), greater than Covalon Technologies Ltd. (37.47M), greater than Speakeasy Cannabis Club Ltd. (2.97M), greater than ZIVO Bioscience, Inc. (39.26M), greater than Vicapsys Life Sciences, Inc. (49.13M),

Build a custom stock screener for Arch Biopartners Inc. (ACHFF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arch Biopartners Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arch Biopartners Inc. (ACHFF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arch Biopartners Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.